These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14702430)

  • 1. Use of antiviral drugs to prevent herpesvirus transmission.
    Crumpacker CS
    N Engl J Med; 2004 Jan; 350(1):67-8. PubMed ID: 14702430
    [No Abstract]   [Full Text] [Related]  

  • 2. Time to refocus on HSV interventions for HIV prevention?
    Tanton C; Abu-Raddad LJ; Weiss HA
    J Infect Dis; 2011 Dec; 204(12):1822-6. PubMed ID: 21998480
    [No Abstract]   [Full Text] [Related]  

  • 3. Herpes simplex virus: a new era?
    Van de Perre P; Nagot N
    Lancet; 2012 Feb; 379(9816):598-9. PubMed ID: 22226046
    [No Abstract]   [Full Text] [Related]  

  • 4. Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
    Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M;
    N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes treatment may limit HIV transmission and progression.
    Wilkinson E
    Lancet Infect Dis; 2007 Apr; 7(4):249. PubMed ID: 17419138
    [No Abstract]   [Full Text] [Related]  

  • 6. Labeling updates to genital herpes drug.
    FDA Consum; 2003; 37(6):3. PubMed ID: 14983803
    [No Abstract]   [Full Text] [Related]  

  • 7. Trial shows HSV-2 suppression can reduce HIV shedding.
    IAVI Rep; 2006; 10(1):20. PubMed ID: 16628770
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.
    Baeten JM; Lingappa J; Beck I; Frenkel LM; Pepper G; Celum C; Wald A; Fife KH; Were E; Mugo N; Sanchez J; Essex M; Makhema J; Kiarie J; Farquhar C; Corey L
    J Infect Dis; 2011 Jan; 203(1):117-21. PubMed ID: 21148504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valacyclovir and acute renal failure.
    Chavannes M; Doad RS; Doad GJS
    J Med Assoc Ga; 2016; 105(3):14. PubMed ID: 29809345
    [No Abstract]   [Full Text] [Related]  

  • 10. HSV-2 suppression reduces HIV and HSV shedding.
    Collins S
    GMHC Treat Issues; 2005 Dec; 19(12):11. PubMed ID: 16909510
    [No Abstract]   [Full Text] [Related]  

  • 11. Interrupting transmission of genital herpes.
    Griffiths PD
    Rev Med Virol; 2004; 14(2):67-9. PubMed ID: 15026999
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.
    Mugwanya K; Baeten JM; Mugo NR; Irungu E; Ngure K; Celum C
    J Infect Dis; 2011 Dec; 204(12):1912-7. PubMed ID: 21998479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
    Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists, number 57, November 2004. Gynecologic herpes simplex virus infections.
    ACOG Committee on Practice Bulletins--Gynecology
    Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1111-8. PubMed ID: 15516420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Herpes genitalis].
    Volpi A; Testore GP; Sarrecchia C
    Recenti Prog Med; 1999 Nov; 90(11):571-4. PubMed ID: 10608144
    [No Abstract]   [Full Text] [Related]  

  • 16. [Genital herpes: epidemiology, transmission, clinic, asymptomatic viral excretion, impact on other sexually transmitted diseases, prevention, and treatment].
    Bossi P
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):477-93. PubMed ID: 12122319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valacyclovir. New indication: for genital herpes, simpler administration.
    Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiology. Domino effects from battles against microbes.
    Cohen J
    Science; 2002 Oct; 298(5592):351-3. PubMed ID: 12376683
    [No Abstract]   [Full Text] [Related]  

  • 19. National guideline for the management of genital herpes. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
    Sex Transm Infect; 1999 Aug; 75 Suppl 1():S24-8. PubMed ID: 10616378
    [No Abstract]   [Full Text] [Related]  

  • 20. CLINICAL PRACTICE. Genital Herpes.
    Gnann JW; Whitley RJ
    N Engl J Med; 2016 Aug; 375(7):666-74. PubMed ID: 27532832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.